| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/2009 | US20090054403 Treatment of Post-Traumatic Stress Disorder |
| 02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
| 02/26/2009 | US20090054401 Substituted bicyclic derivatives and use thereof |
| 02/26/2009 | US20090054400 New progesterone receptor modulators |
| 02/26/2009 | US20090054399 Hiv integrase inhibitors |
| 02/26/2009 | US20090054398 Chemical compounds |
| 02/26/2009 | US20090054397 Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 02/26/2009 | US20090054396 Substituted thiophenes and uses thereof |
| 02/26/2009 | US20090054395 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 02/26/2009 | US20090054394 Polymorphisms in mgst3 are associated with elevated alat levels after ximelagatran treatment |
| 02/26/2009 | US20090054393 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 02/26/2009 | US20090054392 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system |
| 02/26/2009 | US20090054391 An aqueous solution comprising a complex of tellurium oxide with a diol and an ammonium salt, used for stimulating cells to produce cytokines and for treating diseases and conditions responsive to increased production of cytokines, such as cancer, autoimmune, neurodegenerative and infectious diseases |
| 02/26/2009 | US20090054390 Use of haptoglobin genotyping in diagnosis and treatment of intraplaque hemorrhage resulting from plaque rupture |
| 02/26/2009 | US20090054389 Topical Composition Comprising an Antibacterial Substance |
| 02/26/2009 | US20090054388 Novel 11 beta-hydroxyandrosta-4-ene-3-ones |
| 02/26/2009 | US20090054387 Method for preparing 4-[17beta-methoxy-17alpha-methoxymethyl-3-oxestra-4,9-dien-11beta-yl]benzaldehyde (E)-oxime (asoprisnil) |
| 02/26/2009 | US20090054386 Compositions and Methods for Inducing Bone Growth and Inhibiting Bone Loss |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090054384 Airway alkalinization as therapy for airway diseases |
| 02/26/2009 | US20090054383 Pharmaceutical compositions |
| 02/26/2009 | US20090054382 Compositions of phosphodiesterase type iv inhibitors |
| 02/26/2009 | US20090054381 Methods for treating respiratory disorders |
| 02/26/2009 | US20090054380 Methods for diagnosing and treating a mycobacterium avium subspecies paratuberculosis infection |
| 02/26/2009 | US20090054379 7-Pyrollyl 9-Aminoacyl Tetracycline Compounds and Methods of Use Thereof |
| 02/26/2009 | US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| 02/26/2009 | US20090054377 Compositions and methods for smoking cessation |
| 02/26/2009 | US20090054376 Benzofuran derivatives with therapeutic activities |
| 02/26/2009 | US20090054374 Methods of treating acute exacerbations of chronic obstructive pulmonary disease |
| 02/26/2009 | US20090054373 Chitin derivatives for hyperlipidemia |
| 02/26/2009 | US20090054372 Combination therapy for weight loss |
| 02/26/2009 | US20090054371 Folic acid-, vitamin b6- and vitamin b12-containing agents and the use thereof |
| 02/26/2009 | US20090054370 treating an individual exhibiting one or more symptoms of bipolar disorder by administering to the individual a therapeutically-effective amount of a uridine composition that provides 1 to 7 grams of uridine per day |
| 02/26/2009 | US20090054369 Pharmaceutical compositions of silicon-containing substituted adenosine nucleoside amide analogs |
| 02/26/2009 | US20090054368 Substituted gemini surfactant compounds |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054366 RNAi MEDIATED KNOCKDOWN OF NUMA FOR CANCER THERAPY |
| 02/26/2009 | US20090054365 RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION |
| 02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 02/26/2009 | US20090054363 Genetic markers and methods for detecting and treating cancers |
| 02/26/2009 | US20090054362 Compounds |
| 02/26/2009 | US20090054361 Pot1 alternative splicing variants |
| 02/26/2009 | US20090054360 Method and Composition for Treating Allergic Diseases |
| 02/26/2009 | US20090054359 Compositions and their uses directed to diacylglycerol acyltransferase 1 |
| 02/26/2009 | US20090054358 Flt3 inhibitors for immune suppression |
| 02/26/2009 | US20090054357 Macrolide compounds endowed with antiinflammatory activity |
| 02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 02/26/2009 | US20090054355 Proliferation Inhibitor Of Helicobacter Pylori Including Alpha-N-Acetyl-Glucosaminyl Bond-Containing Monosaccharide Derivatives |
| 02/26/2009 | US20090054354 Drug and food or drink for improving pancreatic functions |
| 02/26/2009 | US20090054353 Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome |
| 02/26/2009 | US20090054352 Benzene derivative or salt thereof |
| 02/26/2009 | US20090054351 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 02/26/2009 | US20090054343 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 02/26/2009 | US20090054342 Bioactive peptides and method of using same |
| 02/26/2009 | US20090054341 Methods of Treatment Using Exendin Peptides or GLP-1 Peptides |
| 02/26/2009 | US20090054338 Synergisms between repartitioning and immunomodulating compounds |
| 02/26/2009 | US20090054334 Combinatorial improvement of bifunctional drug properties |
| 02/26/2009 | US20090054329 Composition with docosapentaenoic acid |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054315 Counteracting Drug-Induced Obesity Using GLP-1 Agonists |
| 02/26/2009 | US20090054312 SMIPs: Small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| 02/26/2009 | US20090054310 Method for Maximizing Efficacy and Predicting and Minimizing Toxicity of Calcineurin Inhibitor Compounds |
| 02/26/2009 | US20090054308 administering to a patient A therapeutically effective amounts of an endothelin receptor antagonist e.g. ambrisentan, bosentan etc. and (S)-2-amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid to treat pulmonary hypertension |
| 02/26/2009 | US20090054307 Prophylactic and therapeutic agents and uses therefor |
| 02/26/2009 | US20090054306 which binds to cell through ligand and activated by emitted light; photosensitizer is hematoporphyrin; transport ligand is peptide; conjugate of transferrin-hematoporphyrin which destroys cancerous cells in presence of luminol; tissue targeted |
| 02/26/2009 | US20090054304 Heterocyclic modulators of tgr5 for treatment of disease |
| 02/26/2009 | US20090054303 Crystal forms of saxagliptin and processes for preparing same |
| 02/26/2009 | US20090054256 Method evolved for recognition of thrombophilia (mert) |
| 02/26/2009 | US20090054235 Benzoheterocyclylethylbenzamide derivatives |
| 02/26/2009 | US20090053808 Compositions and methods for inhibiting the expression of anti-apoptopic genes |
| 02/26/2009 | US20090053763 Tumor endothelial marker 7-alpha molecules and uses thereof |
| 02/26/2009 | US20090053342 Preparation of microbial oil |
| 02/26/2009 | US20090053336 Method and Formulations for Treating Candidiasis Using Morinda Citrifolia |
| 02/26/2009 | US20090053332 Compositions for diabetes treatment and prophylaxis |
| 02/26/2009 | US20090053329 Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics |
| 02/26/2009 | US20090053328 Nitric Oxide Enhancing Glutamic Acid Compounds, Compositions and Methods of Use |
| 02/26/2009 | US20090053319 Sore Throat Relief Composition And Method of Producing Same |
| 02/26/2009 | US20090053317 Microparticulate systems for the oral administration of biologically active substances |
| 02/26/2009 | US20090053316 Nanoclusters for delivery of therapeutics |
| 02/26/2009 | US20090053315 Thermo-Kinetic Mixing for Pharmaceutical Applications |
| 02/26/2009 | US20090053312 Methodology and Composition for a Skin Lubricant |
| 02/26/2009 | US20090053311 Pharmaceutical Compositions for Treating or Preventing Bone Conditions |
| 02/26/2009 | US20090053310 Novel sustained release dosage form |
| 02/26/2009 | US20090053308 Release-Control Composition |
| 02/26/2009 | US20090053307 Immediate-release therapeutic systems for improved oral absorption of 7-[(e)]-t-buty-loxyminomethyl] camptothecin |
| 02/26/2009 | US20090053306 Pharmaceutical Compositions of a 5-HT2A Serotonin Receptor Modulator Useful for the Treatment of Disorders Related Thereto |
| 02/26/2009 | US20090053305 Pharmaceutical Formulations |
| 02/26/2009 | US20090053304 Composition and method of producing a taste masking formulation of laxatives for bowel cleaning preparation prior to colonoscopy |
| 02/26/2009 | US20090053303 Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes |
| 02/26/2009 | US20090053302 Cancer treatments |
| 02/26/2009 | US20090053299 Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
| 02/26/2009 | US20090053298 constitutive active/androstane receptor (CAR); antisense agents; drug screening; hepatocytes |
| 02/26/2009 | US20090053297 Compositions and methods for less immunogenic protein-lipid complexes |
| 02/26/2009 | US20090053296 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/26/2009 | US20090053295 Regulatable fusion promoters |
| 02/26/2009 | US20090053294 Anti Mineralocorticoid Therapy of Infection |
| 02/26/2009 | US20090053293 Nano Anticancer Micelles of Vinca Alkaloids Entrapped in Polyethylene Glycolylated Phospholipids |
| 02/26/2009 | US20090053292 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 02/26/2009 | US20090053290 Transdermal drug delivery compositions and topical compositions for application on the skin |
| 02/26/2009 | US20090053289 Kit for the treatment of a corn or callus |